Price $3.38 |
Market Cap
127M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
4.93
|
Dividend %
-
|
|
P/CF
1.0
|
P/FCF
-
|
Op. Cash Flow
-43.5K
|
FCF
-0.7
|
|
Op. Margin
-548.10%
|
Net Margin
-982.20%
|
ROE
202.90%
|
ROI
385.80%
|
|
ROA
-327.80%
|
EPS Growth
36.50%
|
Current Ratio
1.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MGC Diagnostics Corp (MGCD) | $8.09 | - | - | 35.3M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $1.32 | - | - | 89.6M | Strong Buy |
| Acura Pharmaceuticals, Inc. (ACUR) | $0.54 | - | - | 5.9M | Strong Buy |
| Perrigo Company PLC (PRGO) | $75.28 | - | 0.90% | 10.03B | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.49 | - | - | 22.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
